# Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study

> **NCT06188637** · PHASE4 · WITHDRAWN · sponsor: **Geert D'Haens**

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Ozanimod Oral Capsule

## Key facts

- **NCT ID:** NCT06188637
- **Lead sponsor:** Geert D'Haens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funder decision
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06188637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06188637, "Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06188637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*